AHRQ reports declining procedure mortality rates
This article was originally published in The Gray Sheet
Mortality rates for six selected inpatient procedures dropped significantly between 1994 and 2004, the Agency for Healthcare Research and Quality 1reports Oct. 10. Abdominal aortic repair deaths decreased from 103 to 74 per 1,000 admissions. Deaths per 1,000 admissions for hip replacement dropped from four to two, and for percutaneous coronary angioplasty from 16 to 12. Inpatient mortality for six selected diagnoses, including heart attack and stroke, also all declined sharply. AHRQ says the mortality improvements can be attributed to a number of factors, including the implementation of new and improved treatments and better technology
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.